Stocks and Investing Stocks and Investing
Tue, December 19, 2023

Derek Archila Maintained (ASND) at Buy with Increased Target to $149 on, Dec 19th, 2023


Published on 2024-10-28 08:03:49 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $137 to $149 on, Dec 19th, 2023.

Derek has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $116 on, Thursday, November 9th, 2023


These are the ratings of the 2 analyists that currently disagree with Derek


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $192 on, Wednesday, November 8th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Friday, September 15th, 2023
Contributing Sources